Is Dare Bioscience Inc (DARE) overvalued? · rev $9.8K
Dare Bioscience Inc (DARE) is a biotechnology company listed on US.
This page asks whether Dare Bioscience Inc (DARE) looks expensive on cached numbers — not a short thesis.
Latest reported DARE revenue for 2024-12-31 was $9.8K. Net income was -$4.1M. Revenue was down 99.7% from 2023-12-31 to 2024-12-31. DARE currently screens at market cap $21.2M.
DARE currently screens at market cap $21.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next DARE 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the DARE stock page for the full model, not this heading.
Not investment advice.